Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 96.58%40.87M | 144.07%40.84M | 234.15%20.79M | -0.18%16.73M | -23.63%10.56M | -39.87%6.22M | -42.66%2.91M | -9.78%16.76M | 7.94%13.83M | 111.38%10.35M |
| Operating income | 96.58%40.87M | 144.07%40.84M | 234.15%20.79M | -0.18%16.73M | -23.63%10.56M | -39.87%6.22M | -42.66%2.91M | -9.78%16.76M | 7.94%13.83M | 111.38%10.35M |
| Cost of sales | -95.28%-25.55M | ---- | ---13.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating expenses | -95.28%-25.55M | -13.08M | ||||||||
| Gross profit | 98.77%15.33M | 7.71M | ||||||||
| Profit from asset sales | ---- | --1.19M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Employee expense | ---- | 4.89%-9.74M | ---- | 25.99%-10.24M | ---- | ---- | ---- | -69.89%-13.83M | ---- | ---- |
| Depreciation and amortization | ---- | -175.72%-8.24M | ---- | 24.34%-2.99M | ---- | ---- | ---- | -112.13%-3.95M | ---- | ---- |
| Impairment and provision | ---- | -445.16%-4.96M | ---- | -56.63%-910K | ---- | ---- | ---- | -807.81%-581K | ---- | ---- |
| -Other impairment is provision | ---- | -445.16%-4.96M | ---- | -56.63%-910K | ---- | ---- | ---- | -807.81%-581K | ---- | ---- |
| Special items of operating profit | 8.90%-8.63M | -227.85%-20.07M | 4.02%-9.47M | -8.18%-6.12M | 11.34%-14.77M | 14.82%-9.87M | -7.58%-5.34M | -124.43%-5.66M | -107.26%-16.66M | -110.62%-11.59M |
| Operating profit | 480.02%6.7M | 72.04%-986K | 51.69%-1.76M | 51.43%-3.53M | -48.66%-4.21M | -194.35%-3.65M | -2,155.08%-2.43M | -221.18%-7.26M | -159.31%-2.83M | -104.46%-1.24M |
| Financing cost | 71.53%-281K | -270.90%-1.49M | ---987K | -30.10%-402K | ---- | ---- | ---- | -209.00%-309K | ---- | ---- |
| Earning before tax | 333.36%6.42M | 36.94%-2.48M | 24.62%-2.75M | 48.10%-3.93M | -48.66%-4.21M | -194.35%-3.65M | -2,155.08%-2.43M | -228.48%-7.57M | -159.31%-2.83M | -104.46%-1.24M |
| Tax | ---600K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| After-tax profit from continuing operations | 311.53%5.82M | 36.94%-2.48M | 24.62%-2.75M | 48.10%-3.93M | -48.66%-4.21M | -194.35%-3.65M | -2,155.08%-2.43M | -229.76%-7.57M | -161.90%-2.83M | -104.46%-1.24M |
| Earning after tax | 311.53%5.82M | 36.94%-2.48M | 24.62%-2.75M | 48.10%-3.93M | -48.66%-4.21M | -194.35%-3.65M | -2,155.08%-2.43M | -229.76%-7.57M | -161.90%-2.83M | -104.46%-1.24M |
| Profit attributable to shareholders | 311.53%5.82M | 36.94%-2.48M | 24.62%-2.75M | 48.10%-3.93M | -48.66%-4.21M | -194.35%-3.65M | -2,155.08%-2.43M | -229.76%-7.57M | -161.90%-2.83M | -104.46%-1.24M |
| Basic earnings per share | 134.20%0.105 | 79.38%-0.087 | -448.21%-0.307 | -256.72%-0.422 | -38.64%-0.061 | -180.00%-0.056 | -2,205.56%-0.0379 | -229.86%-0.1183 | -719.72%-0.044 | -2,122.22%-0.02 |
| Diluted earnings per share | 134.20%0.105 | 79.38%-0.087 | -448.21%-0.307 | -256.72%-0.422 | -38.64%-0.061 | -180.00%-0.056 | -2,205.56%-0.0379 | -229.86%-0.1183 | -719.72%-0.044 | -2,122.22%-0.02 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | -- | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.